|
Teicher, B A; Holden, S A; Crawford, J M (1988) Effects of Fluosol-DA and oxygen breathing on adriamycin antitumor activity and cardiac toxicity in mice. Cancer 61:2196-201
|
|
Teicher, B A; Bernal, S D; Holden, S A et al. (1988) Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity. Cancer Chemother Pharmacol 21:281-5
|
|
Teicher, B A; Herman, T S; Holden, S A et al. (1988) The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo. Cancer Chemother Pharmacol 21:286-91
|
|
Teicher, B A; Holden, S A (1987) Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents. Cancer Treat Rep 71:173-7
|
|
Teicher, B A; Holden, S A; Jacobs, J L (1987) Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity. Cancer Res 47:513-8
|
|
Teicher, B A; Holden, S A; Kelley, M J et al. (1987) Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 47:388-93
|
|
Teicher, B A; Crawford, J M; Holden, S A et al. (1987) Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity. Cancer Res 47:5036-41
|
|
Teicher, B A; Holden, S A; Cathcart, K N (1987) Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X rays. Int J Radiat Oncol Biol Phys 13:1217-24
|
|
Holden, S A; Teicher, B A; Boeheim, K et al. (1987) Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment. Br J Cancer 55:245-8
|
